Alopecia areata after SARS-CoV-2 vaccination

Margaret E. Scollan, Alyssa Breneman, Neha Kinariwalla, Yssra Soliman, Soundos Youssef, Lindsey A. Bordone, Stephanie M. Gallitano

JAAD Case Reports · 2021 · 53 citations · 4 references

DOIFull text

Open access

Concepts

Abstract

Alopecia areata (AA) is a T lymphocyte-mediated autoimmune condition characterized by hair loss due to an inflammatory response targeting the hair follicle. Recent reports have suggested that COVID-19 may trigger a variety of autoimmune conditions, including AA.1,2 Herein, we report 9 cases of AA following SARS-CoV-2 vaccination (Table I; Fig 1).

References

4